Business Description
Pila Pharma AB
ISIN : SE0015988274
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
PILA.Sweden5KC.Germany IPO Date
2021-08-05Description
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.9 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.67 | |||||
Beneish M-Score | -4.93 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.2 | |||||
3-Year EBITDA Growth Rate | 30.7 | |||||
3-Year EPS without NRI Growth Rate | 31.5 | |||||
3-Year FCF Growth Rate | 25.8 | |||||
3-Year Book Growth Rate | -9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.51 | |||||
9-Day RSI | 36.58 | |||||
14-Day RSI | 38.03 | |||||
3-1 Month Momentum % | -25.61 | |||||
6-1 Month Momentum % | -27.64 | |||||
12-1 Month Momentum % | -40.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.27 | |||||
Quick Ratio | 10.27 | |||||
Cash Ratio | 10.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.8 | |||||
Shareholder Yield % | -53.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -700.53 | |||||
Net Margin % | -1496.27 | |||||
EBITDA Margin % | -1381.19 | |||||
FCF Margin % | -823.53 | |||||
OCF Margin % | -823.53 | |||||
ROE % | -240.16 | |||||
ROA % | -195.2 | |||||
ROIC % | -360.12 | |||||
3-Year ROIIC % | -30.88 | |||||
ROCE % | -237.03 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 31.67 | |||||
PB Ratio | 3.55 | |||||
Price-to-Tangible-Book | 3.48 | |||||
EV-to-EBIT | -3.24 | |||||
EV-to-EBITDA | -3.46 | |||||
EV-to-Revenue | 47.8 | |||||
EV-to-FCF | -5.86 | |||||
Price-to-GF-Value | 0.7 | |||||
| Price-to-Net-Current-Asset-Value | 3.48 | |||||
| Price-to-Net-Cash | 3.48 | |||||
Earnings Yield (Greenblatt) % | -30.86 | |||||
FCF Yield % | -16.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pila Pharma AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.102 | ||
| EPS (TTM) (€) | -0.057 | ||
| Beta | -0.6219 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.52 | ||
| Volatility % | 78.98 | ||
| 14-Day RSI | 38.03 | ||
| 14-Day ATR (€) | 0.012353 | ||
| 20-Day SMA (€) | 0.1141 | ||
| 12-1 Month Momentum % | -40.28 | ||
| 52-Week Range (€) | 0.0869 - 0.41 | ||
| Shares Outstanding (Mil) | 45.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pila Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pila Pharma AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-27 | In 53 days | ||
| General meeting for 2026 | 2026-05-19 15:00 | 0.14 (+9.51%) | ||
| Annual report for 2025 | 2026-03-19 | 0.11 (+9.82%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 0.11 (+17.03%) | ||
| Second quarter earnings results for 2025 | 2025-08-27 | 0.18 (+7.35%) | ||
| General meeting for 2025 | 2025-04-29 15:00 | 0.26 (+15.82%) | ||
| Annual report for 2024 | 2025-03-27 | 0.24 (+8.61%) | ||
| Fourth quarter earnings results for 2024 | 2025-02-27 | 0.28 (+6.53%) | ||
| Second quarter earnings results for 2024 | 2024-08-27 | 0.37 (+1.75%) |
Show
Entries
Pila Pharma AB Frequently Asked Questions
What is Pila Pharma AB(FRA:5KC)'s stock price today?
The current price of FRA:5KC is €0.10. The 52 week high of FRA:5KC is €0.41 and 52 week low is €0.09.
When is next earnings date of Pila Pharma AB(FRA:5KC)?
The next earnings date of Pila Pharma AB(FRA:5KC) is 2026-08-27 Est..
Does Pila Pharma AB(FRA:5KC) pay dividends? If so, how much?
Pila Pharma AB(FRA:5KC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pila Pharma AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers